Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase NA 3Phase 2 3Phase 4 2Phase 1 2Phase 2/3 1

Status

Completed 3Unknown 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Conditions

Polycystic Ovary Syndrome 4Menstruation Disturbances 1Insulin Resistance 1Infertility, Female 1

Interventions

Cisplatin 726Carboplatin 609Paclitaxel 579Cyclophosphamide 516Radiotherapy 511Docetaxel 477Fluorouracil 454Gemcitabine 438Doxorubicin 383Capecitabine 362Dexamethasone 328Oxaliplatin 289pembrolizumab 283Leucovorin 283Bevacizumab 275Etoposide 272Vincristine 270Rituximab 246Prednisone 223Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 176Irinotecan 174Methotrexate 171Lenalidomide 137Nivolumab 136Filgrastim 135Epirubicin 129Tamoxifen 128

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Interventional × Contraceptives, Oral × Clear all
NCT03197077 2023-04-07

Elonva_IVM

Universitair Ziekenhuis Brussel

Phase 3 Completed
145 enrolled

Infertility, Female, Polycystic Ovary Syndrome

NCT03843736 2019-10-10

The Role of Dysbiosis of Gut Microbiota in the Pathogenesis of PCOS.

Peking Union Medical College Hospital

Phase 3 Unknown
200 enrolled

Polycystic Ovary Syndrome

NCT00283816 2015-05-15

Impact of Metformin in Teens With Polycystic Ovary Syndrome (PCOS) on Oral Contraceptive Therapy

University of Rochester

Phase 3 Completed
36 enrolled 9 charts

Menstruation Disturbances, Polycystic Ovary Syndrome

NCT00948402 2009-10-14

PED/PEA-15 Protein, PCOS, Obesity, Insulin Sensitivity Indexes, Metformin, Oral Contraceptives

Federico II University

Phase 3 Completed
20 enrolled

Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡